Delfi Diagnostics Company
Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients.
The company was founded in 2019 and is based in Baltimore, Maryland.
Investors
.png)
Headquarters:
Baltimore,Maryland,United States,North America
Funding Status:
private
Employee Number:
101-250
Founded Date:
2019-01-01 00:00:00
Industry:
BioPharma AI
Technology:
Biomarker Discovery & Validation